Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated safety, tolerability, and pharmacokinetics of KL1333 in healthy male volunteers; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melas Syndrome
• Mitochondrial Respiratory Chain Deficiencies

Drugs mentioned

• KL1333

Snippet

Sponsor: Yungjin Pharm. Co., Ltd. | Conditions: MELAS Syndrome, Mitochondrial Respiratory Chain Deficiencies | Phase 1 | Status: COMPLETED